The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version between February and March 2025.
Zepbound got FDA approval to treat obesity and weight loss in November 2023, joining Eli Lilly's other tirzepatide-based drug ...
Zepbound is a prescription injectable medication that’s used for weight loss. You or a caregiver can ... dosing schedule looks like for the drug. You or a caregiver can inject Zepbound under ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
Obesity rates decline in U.S. for first time in decade, driven by Souths medication usage Obesity decline signals potential ...